Clean Biologics
Clean Biologics is a French group with an international perspective, comprising companies Naobios and Clean Cells, located in western France. They offer development, GMP-compliant production of virus-based medicines, and GMP quality control services for the biopharmaceutical sector, adhering to national, regional, and international guidelines. Their core values are trust, respect, and kindness, which are deeply embedded in their corporate culture.
Industries
Nr. of Employees
medium (51-250)
Clean Biologics
4 Rue Nicolas Sadi Carnot, ZA du Point du Jour, 85600 Montaigu-Vendée, France
Products
Assay catalog for biologics quality control
Large portfolio of validated assays for biosafety, identity, purity and potency used across in-process and release testing; includes hundreds of references and extensive qPCR panels.
cGMP BSL3 manufacturing suite (facility offering)
Dedicated BSL3-design GMP manufacturing unit with segregated clean rooms, continuous environmental monitoring and waste decontamination systems for production of high-risk biologics.
NGS-based cGMP identity testing service
High-throughput sequencing workflow integrated into identity testing for regulated sample characterization and traceability.
Assay catalog for biologics quality control
Large portfolio of validated assays for biosafety, identity, purity and potency used across in-process and release testing; includes hundreds of references and extensive qPCR panels.
cGMP BSL3 manufacturing suite (facility offering)
Dedicated BSL3-design GMP manufacturing unit with segregated clean rooms, continuous environmental monitoring and waste decontamination systems for production of high-risk biologics.
NGS-based cGMP identity testing service
High-throughput sequencing workflow integrated into identity testing for regulated sample characterization and traceability.
Services
Clinical-grade campaign manufacturing including seed bank generation, harvest, drug substance and small-scale drug product manufacture under GMP and BSL2/BSL3 containment.
Creation, release testing and secure storage of master and working cell and virus banks for mammalian and non-mammalian substrates.
Comprehensive QC services covering biosafety, identity, purity and potency using a large assay portfolio for in-process and release testing under GMP when required.
Process development programs from R&D scale to clinical manufacturing, including scaling strategies, parameter optimization and process validation support.
Custom design, optimization and regulatory validation of assays (qPCR, dPCR, ELISA, infectivity, RCL) with documentation and qualification for GMP use.
Controlled environment storage for cell banks, virus seed stocks and other biological starting materials with secure long-term archiving.
Clinical-grade campaign manufacturing including seed bank generation, harvest, drug substance and small-scale drug product manufacture under GMP and BSL2/BSL3 containment.
Creation, release testing and secure storage of master and working cell and virus banks for mammalian and non-mammalian substrates.
Comprehensive QC services covering biosafety, identity, purity and potency using a large assay portfolio for in-process and release testing under GMP when required.
Process development programs from R&D scale to clinical manufacturing, including scaling strategies, parameter optimization and process validation support.
Custom design, optimization and regulatory validation of assays (qPCR, dPCR, ELISA, infectivity, RCL) with documentation and qualification for GMP use.
Controlled environment storage for cell banks, virus seed stocks and other biological starting materials with secure long-term archiving.
Expertise Areas
- GMP manufacturing of viral vaccines and viral vectors
- Bioprocess development and scale-up (USP/DSP)
- Cell and virus banking (master/working banks)
- Quality control testing and biosafety assays
Key Technologies
- qPCR panels
- Digital PCR (dPCR)
- Next-generation sequencing (NGS) for identity
- ELISA-based antigen/antibody assays
News & Updates
Celebration of the opening of Clean Cells' new facilities, including laboratory visits and a festive evening.
Distribution of reusable cups made with sustainable material to promote CSR.
Ensuring business continuity and supporting vaccine development during the pandemic.
Development of a new vaccine and biologics manufacturing center supported by government funding.
Milestone celebration of 20 years of operations.
An article discussing the use of CHO cells in research and manufacturing.
Celebration of the opening of Clean Cells' new facilities, including laboratory visits and a festive evening.
Distribution of reusable cups made with sustainable material to promote CSR.
Ensuring business continuity and supporting vaccine development during the pandemic.
Development of a new vaccine and biologics manufacturing center supported by government funding.
Milestone celebration of 20 years of operations.
An article discussing the use of CHO cells in research and manufacturing.